AzTrials
AzTrials

Heart FailureNCT01171040

Left Atrial Distensibility to Predict Prognosis in Consecutive Patients

An observational study of Heart Failure and Atrial Fibrillation, run by Kaohsiung Veterans General Hospital. at 1 site in Taiwan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Left ventricular filling pressure (LVFP) has prognostic significance in patients with heart failure. Traditionally, it should be assessed by invasive method, as cardiac catheterization and Swan-Gung catheter. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Heart Failure, Atrial Fibrillation, Stroke
What is being tested?
Echocardiography, including the measurements of left atrial (LA) distensibility
How many people
2,000 participants
Where
1 siteTaiwan
Study dates
Jul 2009to Jul 2012
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Consecutive patients received echocardiographic examinations

Who may be able to join

  • consecutive patients received echocardiographic examination are willing to participate in this study.

Who cannot join

  • (1) patients with prosthetic mitral valves, or mitral stenosis
  • (2) rhythm other than sinus rhythm
  • (3) age less than 18 years-old
  • (4) inadequate image quality
  • (5) lack of informed consent

Trial locations and contacts

1 site in 1 country.

Jong-Khing Huang, MD contact

886-7-3422121 ext. 1518

irb@vghks.gov.tw

Taiwan1 site, 1 recruiting
  • Kaohsiung Veterans General Hospital

    Kaohsiung, Taiwan, 886

    Jong-Khing Huang, MD, 886-7-3422121 ext. 1518, irb@vghks.gov.tw

    Shih-Hung Hsiao, MD, 886-7-3422121 ext. 2011, a841120@kimo.com

    Recruiting

Other trials in Taiwan

About this study

Official title: Studies on Assessment of Left Atrial Distensibility to Predict Late Prognosis in Consecutive Patients Received Echocardiographic Examination

Left ventricular filling pressure (LVFP) has prognostic significance in patients with heart failure. Traditionally, it should be assessed by invasive method, as cardiac catheterization and Swan-Gung catheter. In advance of new techniques and modality, echocardiography provides some useful parameters for assessing LVFP, such myocardial tissue Doppler imaging. Many articles had documented that peak velocity of early-diastolic trans-mitral inflow velocity divided by early-diastolic velocity over mitral annulus correlated closely to LVFP. However, myocardial tissue Doppler only provides the information of regional myocardium, so patients with regional wall motion abnormality, as coronary artery disease, can't be assessed by this method without handicap. In addition, conduction disturbance, like bundle branch block, also influences the result of myocardial tissue Doppler. For resolving those problems, the investigators had designed a new global parameter to assess LVFP. In the investigators prior study, left atrial distensibility correlated logarithmically to LVFP in patients with severe mitral regurgitation and also in patients with acute myocardial infarction. Left atrial distensibility provided a new viewpoint to assess left ventricular diastolic function and to predict prognosis. This time, to extend left atrial distensibility to general population received echocardiographic examination for predicting prognosis is attempted.

Read the detailed description

Introduction High left ventricular filling pressure (LVFP) have been associated with volume overload in patients with heart failure and have also been correlated to some extent with more severe symptoms and lower survival rates. In a study of more than 1000 patients hospitalized with acute decompensated heart failure, those with persistently elevated LVFP more than 18 mmHg had increased 1-year mortality compared with those with LVFP less than 16 mmHg. Investigators have also demonstrated that acute reduction of LVFP with vasodilator therapy can improve cardiac function and reduce mortality risk, suggesting that LVFP is an appropriate marker of cardiac risk and functional improvement. However, LVFP measurement involves invasive catheterization, limiting its clinical use especially in the outpatient setting. In advance of new techniques and modality, echocardiography provides some useful parameters to assess LVFP, such myocardial tissue Doppler imaging. Many articles had documented that peak velocity of early-diastolic trans-mitral inflow velocity divided by early-diastolic velocity over mitral annulus was closed correlated with LVFP. However, myocardial tissue Doppler only provides the information of regional myocardium, so patients with regional wall motion abnormality, such as coronary artery disease, can't be assessed by this method without handicap. In addition, conduction disturbance, like bundle branch block, also influences the result of myocardial tissue Doppler. For resolving those problems, we will design a new global parameter to assess LVFP. In prior study, we disclosed the logarithmic relationship between LVFP and left atrial distensibility in acute myocardial infarction patient received primary coronary intervention. This time, to extend our conclusion to general population received echocardiographic examination is attempted. Additionally, we infer that left atrial distensibility which indicates LVFP would influence long-term prognosis, including the event rate of cardiovascular event, stroke and death.

Purpose Left atrial size, particularly left atrial volume, has been recognized as a marker of left ventricular diastolic dysfunction. Contrary to flow and tissue Doppler parameters, left atrial volume is independent of acute volume load and therefore may provide a more accurate assessment of acute and chronic left ventricular dysfunction. In addition, the measurement of left atrial volume is lack of some handicaps of tissue Doppler, including regional myocardial dysfunction in coronary artery disease and bundle branch block. In recent studies, end-systolic left atrial volume (maximal left atrial volume) was useful to predict the risk of atrial fibrillation after cardiac surgery. The short-term and long-term prognosis of acute myocardial infarction was also associated with left atrial volume. In patients with mitral regurgitation, it could be used to reliably estimate the regurgitant volume. Despite end-systolic left atrial volume provides prognostic significance in many disease entities, left atrium is filling and empty in dynamic cyclic motion, so we speculate that left atrial distensibility, defined as the percentage change of left atrial volume between end-systolic and end-diastolic phase, has more prognostic power to represent LVFP and to predict the prognosis. Based on the phenomenon of that higher LVFP, which will conduct to and stretch left atrium in diastolic phase, induces left atrial distension and makes the reduction of distensibility between end-systolic and end-diastolic phases, we had proved the logarithmic relationship between left atrial distensibility and LVFP.

Materials and Methods

Subjects:

2000 consecutive patients received echocardiographic examinations will be enrolled. The exclusion criteria are including (1) patients with prosthetic mitral valves or mitral stenosis, (2) rhythm other than sinus rhythm, (3) age more than 18 years-old, (4) inadequate image quality, (5) lack of informed consent.

Traditional echocardiographic measurement and myocardial tissue Doppler:

All studies are performed by experienced sonographers and reviewed by staff cardiologists with advanced training in echocardiography. Left ventricular function is assessed by Simpson's method. Mitral regurgitation is graded with color flow imaging. Mitral inflow is assessed with pulsed wave Doppler echocardiography form the apical 4-chamber view. The Doppler bean is aligned parallel to the direction of flow, and a 1- to 2-mm sample volume is placed between the tips of mitral leaflets during diastole. From the mitral inflow profile, the E- and A-wave velocity, E-deceleration time, and E/A velocity ration are measured. Pulmonary venous flow is recorded with pulsed-wave Doppler with a sample volume placed 1 cm into the right upper pulmonary vein. The flow velocities are recorded, and the ratio of systolic to diastolic forward flow (S/D ratio) is calculated. Doppler tissue imaging of mitral annulus over septal, lateral and inferior borders is also obtained from apical views. Diastolic filling is categorized as normal (grade 0), impaired relaxation (grade 1), pseudonormalization (grade 2), and restrictive (grade 3) by a combination of transmitral and pulmonary flow patterns as validated previously.

Left atrial volume measurement:

Left atrial volume is assessed by the biplane area-length method from apical 4- and 2-chamber views. The volumes are measured at end-systolic (just before mitral valve opening or the largest dimension), pre-atrial contraction (just before P wave), and end-diastolic (the smallest dimension or the onset of QRS complex), using the highest frame rate. The left atrial outlines at those three phases retrace off-line for three consecutive beats, then average. The recesses of the pulmonary veins and the left atrial appendage are excluded. The length of left atrium is that of the perpendicular line measured from the middle of the plane of the mitral annulus to the superior aspect of the left atrium. The left atrial volume is calculated as: 0.85 x 4-chamber area x 2-chamber area ÷ the shorter of the two lengths. The volume is indexed for body surface area. Left atrial distensibility is defined as: (end-systole left atrial volume - end-diastole left atrial volume) ÷ end-systole left atrial volume. Left atrial ejection fraction is calculated as: (pre-atrial contraction volume - end-diastole left atrial volume) ÷ pre-atrial contraction volume.

Follow-up:

Clinical outcomes are determined 1-year after indexed examination. Follow-up included assessment for the occurrence of sudden death, heart failure with hospitalization, atrial fibrillation, stroke, and death (both cardiac and non-cardiac) per 3 months by telephone interview.

Interobserver variability:

In all cases, atrial volume is measured by two observers independently. Interobserver variability is calculated as the difference between the values obtained by the tow observers divided by the mean.

Statistical analysis:

SPSS software is used for statistical analysis. All continuous variables are presented as mean ± standard deviation. Comparison of clinical and echocardiographic characteristics is performed by chi-square analysis for categorical variables and by Student t test for echocardiography and other continuous variables. A p value < 0.05 is considered significant. Patients will be subdivided to four quartiles according to left atrial distensibility. Unadjusted survival curves are produced using the Kaplan-Meier method. The log-rank test is used to compare survival curves. Adjusted survival curves are constructed using variables entered into the Cox model set to their mean values in the total population. The hazard ratio of low left atrial distensibility will be assessed by comparing quartile to quartile.

Being tested
Echocardiography, including the measurements of left atrial (LA) distensibility
Keywords
left atrial distensibility, mortality, heart failure, atrial fibrillation, stroke, prognosis
Medical subject headings
Heart Failure, Atrial Fibrillation, Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Echocardiography, including the measurements of left atrial (LA) distensibilityOther

    The LA volumes were measured at three points: 1) immediately before the mitral valve opening (maximal LV volume or Volmax); 2) at onset of the P-wave on electrocardiography (pre-atrial contraction volume or Volp); and 3) at mitral valve closure (minimal LV volume or Volmin). The LA distensibility was calculated as (Volmax - Volmin)x 100% / Volmin. The LA ejection fraction was calculated as (Volp - Volmin)x 100% / Volp. In all patients, LA volumes were indexed to body surface area (BSA).

Study groups in NCT01171040
Study groupRoleWhat they receive
Consecutive patients received echocardiographic examinationsConsecutive patients received echocardiography are willing to participate in this study.
Receives: Other: Echocardiography, including the measurements of left atrial (LA) distensibility

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. All cause mortality

    All cause mortality and heart failure with re-hospitalization were defined as hard cardiovascular event.

    Measured: 2 years

  2. Heart failure with hospitalization

    Heart failure with re-hospitalization is documented by at least one of the following: worse exercise tolerance and respiratory distress with NYHA class III or IV symptoms, presence of pulmonary rales, or chest radiography showing pulmonary congestion, which needs an augmented decongestive regimen with oral or intravenous medications during an in-hospital stay.

    Measured: 2 years

Secondary outcomes (2)
  1. Atrial fibrillation

    Enrolled patients with intermittent tachycardia will receive Holter's EKG. Any events of atrial fibrillation documented by EKG or Holter, either paroxysmal or persistent, are accounted.

    Measured: 2 years

  2. Stroke

    Stroke is defined as a sudden onset of focal neurological deficit more than 24 hours and confirmed by brain computed tomography or magnetic resonance imaging. Trans-esophageal echocardiography is suggested to clarify whether cardiogenic or not for all patients with stroke.

    Measured: 2 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jul 2010 (estimated)
  2. Study startJul 2009
  3. Primary completionJul 2011 (estimated)
  4. Study completionJul 2012 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
2,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01171040
Sponsor's protocol ID
VGHKS99-015
Status last verified
Jul 2009
First submitted
23 Jul 2010
Last updated
8 Mar 2011
Results posted
No
Data monitoring committee
Yes

Publications

  • Kasner M, Westermann D, Steendijk P, Gaub R, Wilkenshoff U, Weitmann K, Hoffmann W, Poller W, Schultheiss HP, Pauschinger M, Tschope C. Utility of Doppler echocardiography and tissue Doppler imaging in the estimation of diastolic function in heart failure with normal ejection fraction: a comparative Doppler-conductance catheterization study. Circulation. 2007 Aug 7;116(6):637-47. doi: 10.1161/CIRCULATIONAHA.106.661983. Epub 2007 Jul 23.

    PubMed 17646587
  • Agricola E, Galderisi M, Oppizzi M, Melisurgo G, Airoldi F, Margonato A. Doppler tissue imaging: a reliable method for estimation of left ventricular filling pressure in patients with mitral regurgitation. Am Heart J. 2005 Sep;150(3):610-5. doi: 10.1016/j.ahj.2004.10.046.

    PubMed 16169349
  • Appleton CP, Galloway JM, Gonzalez MS, Gaballa M, Basnight MA. Estimation of left ventricular filling pressures using two-dimensional and Doppler echocardiography in adult patients with cardiac disease. Additional value of analyzing left atrial size, left atrial ejection fraction and the difference in duration of pulmonary venous and mitral flow velocity at atrial contraction. J Am Coll Cardiol. 1993 Dec;22(7):1972-82. doi: 10.1016/0735-1097(93)90787-2.

    PubMed 8245357
  • Rossi A, Cicoira M, Zanolla L, Sandrini R, Golia G, Zardini P, Enriquez-Sarano M. Determinants and prognostic value of left atrial volume in patients with dilated cardiomyopathy. J Am Coll Cardiol. 2002 Oct 16;40(8):1425. doi: 10.1016/s0735-1097(02)02305-7.

    PubMed 12392832
  • Simek CL, Feldman MD, Haber HL, Wu CC, Jayaweera AR, Kaul S. Relationship between left ventricular wall thickness and left atrial size: comparison with other measures of diastolic function. J Am Soc Echocardiogr. 1995 Jan-Feb;8(1):37-47. doi: 10.1016/s0894-7317(05)80356-6.

    PubMed 7710749
  • Moller JE, Hillis GS, Oh JK, Seward JB, Reeder GS, Wright RS, Park SW, Bailey KR, Pellikka PA. Left atrial volume: a powerful predictor of survival after acute myocardial infarction. Circulation. 2003 May 6;107(17):2207-12. doi: 10.1161/01.CIR.0000066318.21784.43. Epub 2003 Apr 14.

    PubMed 12695291
  • Beinart R, Boyko V, Schwammenthal E, Kuperstein R, Sagie A, Hod H, Matetzky S, Behar S, Eldar M, Feinberg MS. Long-term prognostic significance of left atrial volume in acute myocardial infarction. J Am Coll Cardiol. 2004 Jul 21;44(2):327-34. doi: 10.1016/j.jacc.2004.03.062.

    PubMed 15261927
  • Hsiao SH, Huang WC, Lin KL, Chiou KR, Kuo FY, Lin SK, Cheng CC. Left atrial distensibility and left ventricular filling pressure in acute versus chronic severe mitral regurgitation. Am J Cardiol. 2010 Mar 1;105(5):709-15. doi: 10.1016/j.amjcard.2009.10.052.

    PubMed 20185021
  • Hsiao SH, Chiou KR. Renal function decline predicted by left atrial expansion index in non-diabetic cohort with preserved systolic heart function. Eur Heart J Cardiovasc Imaging. 2017 May 1;18(5):521-528. doi: 10.1093/ehjci/jew224.

    PubMed 28064152
  • Hsiao SH, Chiou KR. Left atrial expansion index predicts atrial fibrillation in dyspnea. Circ J. 2013;77(11):2712-21. doi: 10.1253/circj.cj-13-0463. Epub 2013 Jul 26.

    PubMed 23892385
  • Hsiao SH, Chiou KR. Left atrial expansion index predicts all-cause mortality and heart failure admissions in dyspnoea. Eur J Heart Fail. 2013 Nov;15(11):1245-52. doi: 10.1093/eurjhf/hft087. Epub 2013 May 22.

    PubMed 23703107

Questions about this trial

What is this clinical trial studying?

An observational study of Heart Failure and Atrial Fibrillation, run by Kaohsiung Veterans General Hospital. at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 8 Mar 2011. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jong-Khing Huang, MD (886-7-3422121 ext. 1518, irb@vghks.gov.tw), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

All cause mortality (time frame: 2 years). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01171040, which also lists 11 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Mar 2011.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in